Gentex Operating Income vs Research Development Analysis

GNTX Stock

USD 30.40 0.52 1.74%

Gentex financial indicator trend analysis is much more than just examining Gentex latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Gentex is a good investment. Please check the relationship between Gentex Operating Income and its Research Development accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gentex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Gentex Stock please use our How to Invest in Gentex guide.

Operating Income vs Research Development

Operating Income vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Gentex Operating Income account and Research Development. At this time, the significance of the direction appears to have strong relationship.

The correlation between Gentex's Operating Income and Research Development is 0.66. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Research Development in the same time period over historical financial statements of Gentex, assuming nothing else is changed. The correlation between historical values of Gentex's Operating Income and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Gentex are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Operating Income i.e., Gentex's Operating Income and Research Development go up and down completely randomly.

Correlation Coefficient

0.66

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Gentex operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Gentex is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Research Development

Most indicators from Gentex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Gentex current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gentex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Gentex Stock please use our How to Invest in Gentex guide.At this time, Gentex's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.06 in 2024, whereas Tax Provision is likely to drop slightly above 74.7 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	619.7M	609.8M	762.6M	800.8M
Total Revenue	1.7B	1.9B	2.3B	2.4B

Gross Profit Total Revenue

Gentex fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Short Term Debt	Intangible Assets	Accounts Payable	Good Will	Property Plant And Equipment Gross	Common Stock Total Equity
Total Assets		0.89	0.99	0.95	-0.36	0.99	0.37	0.96	-0.03	0.42	0.93	0.39	0.13	0.77	0.14	0.93	0.66	0.91	-0.23	0.49	0.23	0.79	0.8	0.9	0.65	0.79
Total Current Liabilities	0.89		0.93	0.94	-0.26	0.9	0.11	0.89	0.31	0.15	0.94	0.13	-0.23	0.91	-0.12	0.93	0.37	0.77	-0.47	0.63	0.18	0.57	0.93	0.75	0.82	0.56
Total Stockholder Equity	0.99	0.93		0.97	-0.37	0.99	0.3	0.95	0.06	0.36	0.97	0.3	-0.02	0.83	0.02	0.97	0.53	0.9	-0.34	0.6	0.27	0.71	0.84	0.86	0.7	0.75
Property Plant And Equipment Net	0.95	0.94	0.97		-0.29	0.95	0.18	0.93	0.14	0.25	0.96	0.29	-0.09	0.89	-0.06	0.96	0.46	0.84	-0.34	0.66	0.19	0.61	0.9	0.78	0.77	0.63
Net Debt	-0.36	-0.26	-0.37	-0.29		-0.44	-0.85	-0.11	0.52	-0.86	-0.25	-0.49	0.01	-0.1	-0.5	-0.25	-0.15	-0.7	-0.18	0.03	-0.39	-0.05	-0.03	-0.08	0.11	-0.48
Retained Earnings	0.99	0.9	0.99	0.95	-0.44		0.42	0.93	-0.07	0.47	0.92	0.41	0.1	0.76	0.17	0.92	0.62	0.93	-0.24	0.47	0.28	0.75	0.78	0.87	0.62	0.8
Cash	0.37	0.11	0.3	0.18	-0.85	0.42		0.16	-0.75	0.96	0.12	0.71	0.52	-0.13	0.85	0.1	0.57	0.65	0.51	-0.41	0.21	0.35	-0.12	0.23	-0.28	0.57
Non Current Assets Total	0.96	0.89	0.95	0.93	-0.11	0.93	0.16		0.13	0.2	0.93	0.25	0.13	0.78	0.01	0.92	0.64	0.76	-0.33	0.53	0.16	0.83	0.83	0.94	0.72	0.7
Non Currrent Assets Other	-0.03	0.31	0.06	0.14	0.52	-0.07	-0.75	0.13		-0.82	0.26	-0.72	-0.64	0.51	-0.72	0.25	-0.44	-0.28	-0.67	0.53	-0.37	-0.18	0.48	0.02	0.7	-0.33
Cash And Short Term Investments	0.42	0.15	0.36	0.25	-0.86	0.47	0.96	0.2	-0.82		0.16	0.74	0.46	-0.09	0.75	0.17	0.53	0.7	0.44	-0.3	0.39	0.36	-0.09	0.26	-0.31	0.63
Net Receivables	0.93	0.94	0.97	0.96	-0.25	0.92	0.12	0.93	0.26	0.16		0.11	-0.16	0.89	-0.17	0.99	0.4	0.8	-0.49	0.72	0.23	0.62	0.9	0.82	0.79	0.64
Common Stock Shares Outstanding	0.39	0.13	0.3	0.29	-0.49	0.41	0.71	0.25	-0.72	0.74	0.11		0.61	-0.01	0.66	0.12	0.65	0.55	0.69	-0.28	0.05	0.34	0.03	0.2	-0.16	0.33
Non Current Liabilities Total	0.13	-0.23	-0.02	-0.09	0.01	0.1	0.52	0.13	-0.64	0.46	-0.16	0.61		-0.4	0.73	-0.19	0.82	0.12	0.71	-0.64	-0.21	0.54	-0.28	0.27	-0.37	0.3
Inventory	0.77	0.91	0.83	0.89	-0.1	0.76	-0.13	0.78	0.51	-0.09	0.89	-0.01	-0.4		-0.37	0.91	0.16	0.64	-0.5	0.8	-0.03	0.35	0.96	0.58	0.94	0.39
Other Current Assets	0.14	-0.12	0.02	-0.06	-0.5	0.17	0.85	0.01	-0.72	0.75	-0.17	0.66	0.73	-0.37		-0.2	0.63	0.32	0.67	-0.72	-0.06	0.35	-0.32	0.13	-0.38	0.37
Other Stockholder Equity	0.93	0.93	0.97	0.96	-0.25	0.92	0.1	0.92	0.25	0.17	0.99	0.12	-0.19	0.91	-0.2		0.37	0.8	-0.49	0.76	0.24	0.62	0.88	0.81	0.79	0.64
Total Liab	0.66	0.37	0.53	0.46	-0.15	0.62	0.57	0.64	-0.44	0.53	0.4	0.65	0.82	0.16	0.63	0.37		0.58	0.4	-0.24	-0.08	0.86	0.28	0.71	0.13	0.64
Total Current Assets	0.91	0.77	0.9	0.84	-0.7	0.93	0.65	0.76	-0.28	0.7	0.8	0.55	0.12	0.64	0.32	0.8	0.58		-0.04	0.35	0.3	0.6	0.62	0.69	0.43	0.81
Short Long Term Debt Total	-0.23	-0.47	-0.34	-0.34	-0.18	-0.24	0.51	-0.33	-0.67	0.44	-0.49	0.69	0.71	-0.5	0.67	-0.49	0.4	-0.04		-0.68	-0.36	-0.06	-0.48	-0.33	-0.52	-0.1
Other Current Liab	0.49	0.63	0.6	0.66	0.03	0.47	-0.41	0.53	0.53	-0.3	0.72	-0.28	-0.64	0.8	-0.72	0.76	-0.24	0.35	-0.68		0.24	0.07	0.71	0.35	0.7	0.17
Short Term Debt	0.23	0.18	0.27	0.19	-0.39	0.28	0.21	0.16	-0.37	0.39	0.23	0.05	-0.21	-0.03	-0.06	0.24	-0.08	0.3	-0.36	0.24		0.18	-0.04	0.26	-0.27	0.34
Intangible Assets	0.79	0.57	0.71	0.61	-0.05	0.75	0.35	0.83	-0.18	0.36	0.62	0.34	0.54	0.35	0.35	0.62	0.86	0.6	-0.06	0.07	0.18		0.43	0.94	0.32	0.74
Accounts Payable	0.8	0.93	0.84	0.9	-0.03	0.78	-0.12	0.83	0.48	-0.09	0.9	0.03	-0.28	0.96	-0.32	0.88	0.28	0.62	-0.48	0.71	-0.04	0.43		0.64	0.92	0.41
Good Will	0.9	0.75	0.86	0.78	-0.08	0.87	0.23	0.94	0.02	0.26	0.82	0.2	0.27	0.58	0.13	0.81	0.71	0.69	-0.33	0.35	0.26	0.94	0.64		0.53	0.76
Property Plant And Equipment Gross	0.65	0.82	0.7	0.77	0.11	0.62	-0.28	0.72	0.7	-0.31	0.79	-0.16	-0.37	0.94	-0.38	0.79	0.13	0.43	-0.52	0.7	-0.27	0.32	0.92	0.53		0.24
Common Stock Total Equity	0.79	0.56	0.75	0.63	-0.48	0.8	0.57	0.7	-0.33	0.63	0.64	0.33	0.3	0.39	0.37	0.64	0.64	0.81	-0.1	0.17	0.34	0.74	0.41	0.76	0.24

Click cells to compare fundamentals

Gentex Account Relationship Matchups

Gentex fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.2B	2.2B	2.1B	2.3B	2.6B	2.7B
Total Current Liabilities	171.8M	177.7M	181.7M	250.6M	271.6M	285.2M
Total Stockholder Equity	1.9B	2.0B	1.9B	2.1B	2.3B	2.4B
Property Plant And Equipment Net	498.3M	468.1M	464.1M	550.0M	652.9M	685.5M
Net Debt	(296.3M)	(423.4M)	(262.3M)	(214.8M)	(222.9M)	(234.0M)
Retained Earnings	1.1B	1.1B	1.0B	1.1B	1.3B	1.4B
Cash	296.3M	423.4M	262.3M	214.8M	226.4M	242.1M
Non Current Assets Total	1.2B	1.2B	1.3B	1.4B	1.6B	1.7B
Non Currrent Assets Other	(51.5B)	(39.0B)	(4.8M)	(25.5M)	(1.0)	(1.05)
Cash And Short Term Investments	436.7M	450.5M	267.7M	237.8M	240.8M	274.3M
Net Receivables	235.4M	284.9M	249.8M	276.5M	321.8M	337.9M
Common Stock Shares Outstanding	253.3M	243.7M	236.6M	231.2M	229.7M	290.5M
Liabilities And Stockholders Equity	2.2B	2.2B	2.1B	2.3B	2.6B	2.7B
Non Current Liabilities Total	58.9M	56.3M	11.7M	10.9M	27.3M	50.8M
Inventory	248.9M	226.3M	316.3M	404.4M	402.5M	422.6M
Other Current Assets	29.3M	17.6M	39.2M	30.0M	32.7M	31.0M
Other Stockholder Equity	807.9M	852.8M	879.4M	917.5M	968.2M	1.0B
Total Liab	230.7M	234.0M	193.4M	261.4M	298.9M	313.9M
Total Current Assets	950.4M	979.3M	873.0M	948.7M	997.7M	1.0B
Other Current Liab	74.3M	89.2M	83.1M	80.1M	84.7M	88.9M
Intangible Assets	272.8M	276.5M	272.6M	312.4M	280.5M	294.5M
Accounts Payable	97.6M	84.8M	98.3M	151.7M	184.4M	193.6M
Property Plant And Equipment Gross	498.3M	468.1M	1.3B	1.5B	1.6B	1.7B
Accumulated Other Comprehensive Income	(1.3M)	6.9M	1.9M	(14.1M)	(6.6M)	(6.2M)
Common Stock Total Equity	15.1M	14.6M	14.2M	14.1M	16.2M	11.4M
Short Term Investments	140.4M	27.2M	5.4M	23.0M	14.4M	13.6M
Common Stock	15.1M	14.6M	14.2M	14.1M	13.9M	11.5M
Property Plant Equipment	498.3M	468.1M	464.1M	550.0M	632.5M	333.1M
Net Tangible Assets	1.9B	2.0B	1.4B	2.1B	2.4B	1.8B
Retained Earnings Total Equity	1.1B	1.1B	1.0B	1.1B	1.3B	983.3M
Capital Surpluse	807.9M	852.8M	879.4M	917.5M	1.1B	710.9M
Deferred Long Term Liab	58.9M	54.5M	51.5M	39.0M	44.8M	52.8M
Accumulated Depreciation	(728.8M)	(789.1M)	(860.4M)	(928.3M)	(835.5M)	(877.3M)
Other Liab	58.5M	56.3M	11.7M	10.2M	9.1M	8.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Gentex Stock Analysis

When running Gentex's price analysis, check to measure Gentex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gentex is operating at the current time. Most of Gentex's value examination focuses on studying past and present price action to predict the probability of Gentex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gentex's price. Additionally, you may evaluate how the addition of Gentex to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Gentex Operating Income vs Research Development Analysis

Operating Income vs Research Development

Operating Income vs Research Development Correlation Analysis

Correlation Coefficient

Operating Income

Research Development

Gentex fundamental ratios Correlations

Gentex Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Gentex fundamental ratios Accounts

Also Currently Popular

Additional Tools for Gentex Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity
Other Stockholder Equity	+ 0.99	Net Receivables
Property Plant And Equipment Net	+ 0.97	Total Stockholder Equity
Net Receivables	+ 0.97	Total Stockholder Equity

Cash And Short Term Investments	- 0.86	Net Debt
Cash	- 0.85	Net Debt
Cash And Short Term Investments	- 0.82	Non Currrent Assets Other
Non Currrent Assets Other	- 0.75	Cash
Other Current Liab	- 0.72	Other Current Assets
Other Current Assets	- 0.72	Non Currrent Assets Other